Clinical Trial Detail

NCT ID NCT02870244
Title Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Loyola University
Indications

melanoma

Therapies

Autologous TIL 13831 TCR transduced T cells

Age Groups: senior adult

No variant requirements are available.